Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin

Author： Bagley K.C.   Shata M.T.   Onyabe D.Y.   DeVico A.L.   Fouts T.R.   Lewis G.K.   Hone D.M.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.23, 2003-07, pp. : 3335-3341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine

By Cryz S.J.   Goldstein H.   Pettoello-Mantovani M.   Kim A.   Furer E.   Que J.U.   Hasler T.   Rubinstein A.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite

Immunogenicity of plasmid DNA encoding the 62 kDa fragment of Schistosoma japonicum myosin

By Zhang Y.Y.   Taylor M.G.   Gregoriadis G.   McCrossan M.V.   Bickle Q.D.  

Vaccine, Vol. 18, Iss. 20, 2000-04 ,pp. : 2102-2109

Elsevier

Access to resources Recommend Favorite

Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems

By Sjolander S.   Hansen J.-E.S.   Lovgren-Bengtsson K.   &   9kerblom L.   Morein B.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 344-352

Elsevier

Access to resources Recommend Favorite

Mucosal immunogenicity and adjuvanticity of cholera toxin in swine

By Foss D.L.   Murtaugh M.P.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 788-801

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

By Kanesa-thasan N.   Sun W.   Kim-Ahn G.   Van Albert S.   Putnak J.R.   King A.   Raengsakulsrach B.   Christ-Schmidt H.   Gilson K.   Zahradnik J.M.   Vaughn D.W.   Innis B.L.   Saluzzo J.-F.   Hoke Jr C.H.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3179-3188

Elsevier

Access to resources Recommend Favorite